In addition, cleaved caspase-3 and PARP cleavage increased significantly in the combination-treated group while VPA or DOX alone had no effect or only a slight effect (Figure 2C,D), which confirmed the synergistic cytotoxicity of the VPA and DOX combination treatment in HCC. The gene discussed is PARP1; the disease is hepatocellular carcinoma.